Current Report Filing (8-k)
August 22 2016 - 4:26PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT Pursuant
to
Section 13 or 15(
d
)
of the
Securities
Exchange Act of 1934
Date
of report (Date of earliest event reported):
August 16, 2016
Solitron
Devices, Inc.
|
(Exact
Name of Registrant as Specified in Its Charter)
|
Delaware
|
(State
or Other Jurisdiction of Incorporation)
|
001-04978
|
|
22-1684144
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
3301
Electronics Way, West Palm Beach, Florida
|
|
33407
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
(561)
848-4311
|
(Registrant’s
Telephone Number, Including Area Code)
|
|
(Former
Name or Former Address, if Changed Since Last Report)
|
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (
see
General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section
4 – Matters Related to Accountants and Financial Statements
Item 4.01.
|
Changes in Registrant's Certifying Accountant.
|
On
August 16, 2016, the practice of Goldstein Schechter Koch, P.A. ("GSK"), which was engaged as the independent registered
public accounting firm of Solitron Devices, Inc. ("Solitron" or the "Company"), was combined with BDO USA,
LLP ("BDO") and the professional staff and partners of GSK joined BDO either as employees or partners of BDO. As a result
of the transaction, GSK resigned as Solitron's independent registered public accounting firm on August 16, 2016. Solitron's Board
of Directors intends to consider the appointment of a new independent registered public accounting firm in the near future.
The
report of the independent registered public accounting firm of GSK regarding the Company's financial statements for the fiscal
years ended February 29, 2016 and February 28, 2015 did not contain any adverse opinion or disclaimer of opinion and were not
qualified or modified as to uncertainty, audit scope or accounting principles. During the fiscal years ended February 29, 2016
and February 28, 2015, and during the interim period from the end of the most recently completed fiscal year through August 16,
2016, the date of resignation, there were no disagreements with GSK on any matter of accounting principles or practices, financial
statement disclosure or auditing scope or procedure, which disagreements, if not resolved to the satisfaction of GSK, would have
caused it to make reference to such disagreement in its reports; and there were no reportable events as described in paragraph
(a)(i)(v) of Item 304 of Regulation SK.
The
Company provided GSK with a copy of this Current Report on Form 8-K (the "Report") prior to its filing with the
Securities and Exchange Commission ("SEC") and requested that GSK furnish the Company with a letter addressed to the
SEC stating whether it agrees with the above statements and, if it does not agree, the respects in which it does not agree. A
copy of the letter has been filed as an exhibit to this Report.
Section
9 – Financial Statements and Exhibits
Item 9.01.
|
Financial Statements and Exhibits.
|
(d)
Exhibits
Exhibit
No.
|
|
Description
|
16.1
|
|
Letter,
dated August 22, 2016, from Goldstein Schechter Koch, P.A.
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
August
22, 2016
|
SOLITRON
DEVICES, INC.
|
|
|
|
/s/
Tim Eriksen
|
|
Tim
Eriksen
|
|
Chief
Executive Officer
|
EXHIBIT
INDEX
Exhibit
No.
|
|
Description
|
16.1
|
|
Letter,
dated August 22, 2016, from Goldstein Schechter Koch, P.A.
|
4
Solitron Devices (PK) (USOTC:SODI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Solitron Devices (PK) (USOTC:SODI)
Historical Stock Chart
From Apr 2023 to Apr 2024